# Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.

> **NCT02586961** · PHASE2,PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 195 (actual)

## Conditions studied

- Children
- Bronchiolitis

## Interventions

- **DRUG:** 0.9% saline solution
- **DRUG:** oral betamethasone placebo
- **DRUG:** adrenaline
- **DRUG:** oral betamethasone

## Key facts

- **NCT ID:** NCT02586961
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-09
- **Final completion:** 2017-10
- **Target enrollment:** 195 (ACTUAL)
- **Why stopped:** Removal of Adrénaline lots for safety reasons.
- **Last updated:** 2017-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586961, "Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02586961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*